Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Musculoskeletal | Rheumatology | Nephrology
Disease Category: Systemic Lupus Erythematosus
Location: United States, NY
Systemic Lupus Erythematosus (SLE)
Patients with Systemic Lupus Erythematosus (SLE) are asked to participate in the ILLUMINATE research study program being
conducted by The Feinstein Institute for Medical Research.
You may be eligible to participate in this study if you:
Individuals who qualify will receive study medication and all study-related care at no charge. Reimbursement for study-related travel and time will be provided. Some standard lupus medications will also be permitted during study participation.
CW ID: 170219
Date Last Changed:
July 23, 2013
Sanita Kandasami, Study CoordinatorBiomedical Research Alliance of New YorkFeinstein Institute for Medical Research,
350 Community Drive,Manhasset, NY 11030Phone: 516-562-2401Fax: 516-562-2537
Biomedical Research Alliance of New York
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2016 CenterWatch.